Studies have reported that high caspase-3 expression is associated with adverse survival in breast cancer patients (41, 42) and other cancers that include gastric, ovarian, cervical, colorectal, and lung cancer (43, 44). This evidence concerns the gene CASP3 and lung carcinoma.